Sura Alqaisi
Endocrinology, Diabetes & Metabolism Physician · Pittsburgh, PA
Sura Alqaisi is an endocrinology, diabetes & metabolism physician with a practice address in Pittsburgh, Pennsylvania, and NPI 1053872440, issued on Mar 27, 2019. Check the license (Pennsylvania MTD484651, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Sura Alqaisi
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License numbers
- MTD484651 PA
V8573 TX
Self-reported in NPPES; status is on the state search - Practice location
- 3601 Fifth Avenue - Falk Medical Building, Pittsburgh, PA 15213
- Phone
- (412) 586-9700
- Enumerated
- Mar 27, 2019
- Record last updated
- Mar 6, 2026
- Fax
- (412) 586-9726
- Medicaid ID
- 1053872440 OH
- Medicare enrollment
- Enrolled (PECOS I20240816003314); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 485 in Pennsylvania → Look up another NPI →
Verify Sura Alqaisi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MTD484651Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
90% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
251 Medicare Part D claims for 72 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 55% of claims.
Most prescribed
- Mounjaro26 claims
- Lantus Solostar20 claims
- Hydrocortisone18 claims
- Levothyroxine Sodium15 claims
- Trulicity13 claims
- Nano 2nd Gen Pen Needle11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $720.82
12 payments; by number, the most common kind was food and beverage; the largest payer was Medtronic, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- University OF Pittsburgh PhysiciansPittsburgh, PA
- Utmb Faculty Group PracticeGalveston, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Sura Alqaisi among 485 endocrinology, diabetes & metabolism physician records in Pennsylvania
Sura Alqaisi is one of 485 endocrinology, diabetes & metabolism physician records with a practice address in Pennsylvania. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2019, is newer than 90% of them.
- NPI issued2019 · 90% of these records are older, 6% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 69% of these records are
- Graduated2008 · median 2004 among the 334 with a school on file
- Record last updated2026 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Pennsylvania
There are 485 endocrinology, diabetes & metabolism physician records in Pennsylvania.
All 485 in Pennsylvania → Every provider in Pittsburgh → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Ronald Codario, M.D.Pittsburgh, PA 152131568655900
- Pouneh Fazeli, MDPittsburgh, PA 152131497732887
- Melody Ives, CRNPPittsburgh, PA 152131003985250
- Esra Karslioglu FrenchPittsburgh, PA 152131093907305
- Erin Kershaw, MDPittsburgh, PA 152131346228228
- Helena LevittPittsburgh, PA 152131699988493
- Hussain MahmudPittsburgh, PA 152131336333210
- Jason Ng, M.D.Pittsburgh, PA 152131619135795
Common questions
What is Sura Alqaisi's NPI number?
Sura Alqaisi's National Provider Identifier (NPI) is 1053872440, issued on Mar 27, 2019. An NPI identifies a provider in billing; it is not a license.
Where is Sura Alqaisi located?
The NPPES record lists a practice address at 3601 Fifth Avenue - Falk Medical Building, Pittsburgh, PA, 15213. Phone: (412) 586-9700. Providers update this record themselves, so call before visiting.
How can I verify Sura Alqaisi's license?
NPPES lists Pennsylvania license number MTD484651, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Sura Alqaisi prescribe under Medicare Part D?
In 2024, Sura Alqaisi had 251 Medicare Part D claims for 72 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.